Pancreatitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with pancreatic cancer
- People who are considered high-risk for developing pancreatic cancer
- People who have been diagnosed with certain non-cancerous or less aggressive pancreatic tumors, such as solid pseudopapillary tumors or neuroendocrine tumors of the pancreas
- People who have other medical conditions that have caused their CA19-9 blood marker levels to be unusually high (CA19-9 is a protein sometimes linked to pancreatic cancer)
- People who have no pancreatic disease and normal CA19-9 levels based on blood tests and imaging scans (these individuals would be part of a comparison group)
Who may not be able to join:
- People who are under 18 years of age
- People who are suspected of having a cancerous growth in the pancreas but have not yet received a confirmed diagnosis through imaging scans or tissue testing
- People who have not signed the required consent form agreeing to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ning Zhong, MD, Qilu Hospital of Shandong University
Phone: 18560086106
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The diagnostic value (sensitivity, specificity, accuracy, and positive and negative predictive values)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.